Evidence map›Paper›PMID 36517479›Full record

ArticleNature communications2022

Optimal deep brain stimulation sites and networks for stimulation of the fornix in Alzheimer's disease.

Ana Sofía Ríos, Simón Oxenford, Clemens Neudorfer, Konstantin Butenko, Ningfei Li, Nanditha Rajamani, Alexandre Boutet, Gavin J B Elias, Jurgen Germann, Aaron Loh and 22 more

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 59 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 1 pooled it
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00658125 nacompletednot on this map

Modulation of Cognitive Function Using Electrical Brain Stimulation in Patients With Early Alzheimer Disease

TypeinterventionalSponsorUniversity Health Network, TorontoRan2007 to 2010Enrolled6ConditionsAlzheimer DiseaseArmsBilateral fornix DBS implantation,
NCT01608061 nacompletednot on this map

A Twelve Month Double-blind Randomized Controlled Feasibility Study to Evaluate the Safety, Efficacy and Tolerability of Deep Brain Stimulation of the Fornix (DBS-f) in Patients With Mild Probable Alzheimer's Disease

TypeinterventionalSponsorFunctional Neuromodulation LtdRan2012 to 2018Enrolled42ConditionsAlzheimer DiseaseArmsDBS-f on, DBS-f off
3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 1 synthesis or guideline pooled it, 93 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Linking Invasive and Noninvasive Brain Stimulation in Parkinson's Disease: A Randomized Trial.Movement disorders : official journal of the Movement Disorder Society · 2024
    Trial
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Optimal Deep Brain Stimulation Locations for Gilles de la Tourette Syndrome.medRxiv : the preprint server for health sciences · 2026
    Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. A Multi-Symptom Circuit Architecture of Obsessive-Compulsive Disorder.medRxiv : the preprint server for health sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 13 institutions in 3 countries.

Ana Sofía RíosMovement Disorder and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Simón OxenfordMovement Disorder and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID 0000-0003-2989-3861
Clemens NeudorferMovement Disorder and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Konstantin ButenkoMovement Disorder and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Ningfei LiMovement Disorder and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID 0000-0003-3315-3591
Nanditha RajamaniMovement Disorder and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Alexandre BoutetDivision of Neurosurgery, Department of Surgery, University Health Network and University of Toronto, Toronto, ON, M5T2S8, Canada.ORCID 0000-0001-6942-5195
Gavin J B EliasDivision of Neurosurgery, Department of Surgery, University Health Network and University of Toronto, Toronto, ON, M5T2S8, Canada.ORCID 0000-0002-7495-550X
Jurgen GermannDivision of Neurosurgery, Department of Surgery, University Health Network and University of Toronto, Toronto, ON, M5T2S8, Canada.ORCID 0000-0003-0995-8226
Aaron LohDivision of Neurosurgery, Department of Surgery, University Health Network and University of Toronto, Toronto, ON, M5T2S8, Canada.
Wissam DeebUMass Chan Medical School, Department of Neurology, Worcester, MA, 01655, USA.
Fuyixue WangAthinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Harvard Medical School, Massachusetts General Hospital, Charlestown, MA, USA.ORCID 0000-0001-8975-2775
Kawin SetsompopAthinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Harvard Medical School, Massachusetts General Hospital, Charlestown, MA, USA.
Bryan SalvatoUniversity of Florida Health Jacksonville, Jacksonville, FL, USA.
Leonardo Brito de AlmeidaNorman Fixel Institute for Neurological Diseases, Departments of Neurology and Neurosurgery, University of Florida, Gainesville, FL, USA.
Kelly D FooteNorman Fixel Institute for Neurological Diseases, Departments of Neurology and Neurosurgery, University of Florida, Gainesville, FL, USA.ORCID 0000-0002-2436-4138
Robert AmaralCerebral Imaging Centre, Douglas Research Centre, Montreal, QC, Canada.
Paul B RosenbergDepartment of Psychiatry and Behavioral Sciences and Richman Family Precision Medicine Center of Excellence, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
David F Tang-WaiKrembil Research Institute, University of Toronto, Toronto, ON, M5T2S8, Canada.
David A WolkDepartment of Neurology, University of Pennsylvania, Philadelphia, PA, USA.
Anna D BurkeBarrow Neurological Institute, Phoenix, AZ, USA.
Stephen SallowayDepartment of Psychiatry and Human Behavior and Neurology, Alpert Medical School of Brown University, Providence, RI, USA.ORCID 0000-0002-2631-0942
Marwan N SabbaghBarrow Neurological Institute, Phoenix, AZ, USA.
M Mallar ChakravartyCerebral Imaging Centre, Douglas Research Centre, Montreal, QC, Canada.
Gwenn S SmithDepartment of Psychiatry and Behavioral Sciences and Richman Family Precision Medicine Center of Excellence, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.ORCID 0000-0003-0706-5440
Constantine G LyketsosDepartment of Psychiatry and Behavioral Sciences and Richman Family Precision Medicine Center of Excellence, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Michael S OkunNorman Fixel Institute for Neurological Diseases, Departments of Neurology and Neurosurgery, University of Florida, Gainesville, FL, USA.ORCID 0000-0002-6247-9358
William S AndersonJohns Hopkins School of Medicine, Baltimore, MD, USA.ORCID 0000-0003-0958-050X
Zoltan MariJohns Hopkins School of Medicine, Baltimore, MD, USA.ORCID 0000-0003-0356-9879
Francisco A PonceBarrow Neurological Institute, Phoenix, AZ, USA.
Andres M LozanoDivision of Neurosurgery, Department of Surgery, University Health Network and University of Toronto, Toronto, ON, M5T2S8, Canada.ORCID 0000-0001-8257-3694
Andreas HornMovement Disorder and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. ahorn1@bwh.harvard.edu.ORCID 0000-0002-0695-6025
Humboldt-Universität zu Berlin · DEUniversity Health Network · CAJohns Hopkins University · USBarrow Neurological Institute · USUniversity of Florida · USHarvard University · USBrigham and Women's Hospital · USCleveland Clinic · USMcGill University · CAProvidence College · USUMass Memorial Health Care · USUniversity of Florida Health · USUniversity of Pennsylvania · US

Funding

Research Education ComponentP30AG066507 · NIA · JOHNS HOPKINS UNIVERSITY · PI MARILYN S. ALBERT · 2020 to 2026
$29.3M
Research Education ComponentP30AG072979 · NIA · UNIVERSITY OF PENNSYLVANIA · PI DAVID A WOLK · 2021 to 2026
$24.8M
Using human brain connectivity to identify the causal neuroanatomical substrate of depression symptomsR01MH113929 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI MICHAEL D FOX · 2017 to 2026
$6.9M
Toward Connectomic Deep Brain Stimulation in Obsessive Compulsive DisorderR01MH130666 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI MICHAEL D FOX · 2022 to 2026
$3.9M
Using Brain Lesions and Deep Brain Stimulation to Identify an Epilepsy CircuitR01NS127892 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI MICHAEL D FOX · 2022 to 2026
$3.4M
NIA NIH HHS P30 AG066507NIA NIH HHS P30 AG072979NIMH NIH HHS R01 MH113929NIMH NIH HHS R01 MH130666NINDS NIH HHS R01 NS127892
6 · The paper itself

Abstract

Deep brain stimulation (DBS) to the fornix is an investigational treatment for patients with mild Alzheimer's Disease. Outcomes from randomized clinical trials have shown that cognitive function improved in some patients but deteriorated in others. This could be explained by variance in electrode placement leading to differential engagement of neural circuits. To investigate this, we performed a post-hoc analysis on a multi-center cohort of 46 patients with DBS to the fornix (NCT00658125, NCT01608061). Using normative structural and functional connectivity data, we found that stimulation of the circuit of Papez and stria terminalis robustly associated with cognitive improvement (R = 0.53, p < 0.001). On a local level, the optimal stimulation site resided at the direct interface between these structures (R = 0.48, p < 0.001). Finally, modulating specific distributed brain networks related to memory accounted for optimal outcomes (R = 0.48, p < 0.001). Findings were robust to multiple cross-validation designs and may define an optimal network target that could refine DBS surgery and programming.

Indexed as

Alzheimer DiseaseDeep Brain StimulationBrainFornix, BrainHumansRandomized Controlled Trials as TopicThalamus

Identifiers

PMID36517479
PMCPMC9751139
OpenAlexW4311399591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.